Food and Drug Law Weekly

Bristol-Myers Squibb - Recent developments in CCR3 antagonists are focus of review

Business Update - Ablatherm-HIFU launches service at first site in Portugal

Business Update - Blue Cross' Healthcare Facts adds Minnesota clinics to drive transparency in healthcare

Business Update - Medicomp contracts with Premier Purchasing Partners for ambulatory Holter monitoring systems

Business Update - The Center for Wound Healing continues expansion in Pennsylvania and West Virginia

CIC-INSERM, France - Gastroesophageal reflux disease diagnosis and therapies reviewed

CSIRO Human Nutrition, Australia - New research from Australia, Greece and Spain in the area of polycystic ovarian syndrome detailed

CV Therapeutics - JCI publishes study evaluating potential of CVT-6883 for treatment of pulmonary conditions

Cell Signaling Technology - Cell Signaling Technology demonstrates discovery capabilities of its PhosphoScan Proteomics Platform

Centre MURAZ, Bobo-Dioulasso, Burkina Faso - Researchers from Laos, Switzerland and the United Kingdom report details of new studies and findings in the area of malaria

Charite-Universitatsmedizin Berlin, Germany - Studies from Germany, the United States and Greece add new findings to breast cancer body of knowledge

ChemGenex Pharmaceuticals - ChemGenex publishes two new clinical studies supporting Ceflatonin beyond CML to other leukemias

China Medical University, Taiwan - Cardiomyoblast-induced apoptosis is synergistically enhanced by angiotensin

Chinese University of Hong Kong, People's Republic of China - Chinese herbal therapy was not effective for irritable bowel syndrome

Cleveland Clinic, U.S. - Intracranial angioplasty and stenting technique in the awake patient is described

Cleveland Clinic, U.S. - No objective response reported in phase II trial of stem cell transplant for renal cell carcinoma

CoTherix - CoTherix reports second quarter results

Cohn & Wolfe Healthcare - Data demonstrate effectiveness of Lamictal for grand mal seizures

Cold Spring Harbor Laboratory, U.S. - Researchers' findings from the United States and Sweden advance neurology research

Concord Hospital, Concord, Australia - Tumors may be exposed to SN-38 by beta-glucuronidase

Crucell - Monoclonal antibodies from individuals infected with West Nile Virus characterized

Debrecen University of Medicine, Hungary - Researchers from Hungary and the United States report details of new studies and findings in the area of diabetes

Diomed - Diomed announces record second quarter results, delivers 27% growth in total revenues

Elekta - Elekta highlights choice of new treatment planning solutions for radiosurgery and radiotherapy

Food and Drug Administration, U.S. - Many drug expiration dates can be extended beyond label value

Food and Drug Administration, U.S. - Recent findings from the United States illuminate research in anthrax

Food and Drug Administration, U.S. - Reports from the United States and Switzerland advance knowledge in stroke research

Hemispherx Biopharma - Hemispherx announces purchase of royalty interest from Stem Cell Innovation

ImClone Systems - ImClone issues statement regarding Repligen litigation

Quintiles Transnational - Steven Niedelman joins Quintiles Consulting as executive vice president

Rational Therapeutics - Ovarian cancer drug combination receives U.S. Food & Drug Administration approval

Repligen - Repligen wins summary judgment against ImClone in Erbitux case

UCB - U.S. FDA approves Keppra Intravenous Formulation

University of Pennsylvania, U.S. - Tigecycline is newly approved glycylcycline antimicrobial agent